UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000019480
Receipt number R000022425
Scientific Title Randomized controlled study of early replacement with factor XIII for fistula after pancreatic surgery (FIPS)
Date of disclosure of the study information 2015/10/25
Last modified on 2020/02/18 10:19:47

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Randomized controlled study of early replacement with factor XIII for fistula after pancreatic surgery (FIPS)

Acronym

RCT of early replacement with factor XIII for pancreatic fistula

Scientific Title

Randomized controlled study of early replacement with factor XIII for fistula after pancreatic surgery (FIPS)

Scientific Title:Acronym

RCT of early replacement with factor XIII for pancreatic fistula

Region

Japan


Condition

Condition

Fistula after pancreatic surgery

Classification by specialty

Hepato-biliary-pancreatic surgery

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate whether coagulation factor XIII promote the cure of fistula after pancreatic surgery.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The length of pancreatic fistula cure after the recovery of inflammation and alimination

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification

YES

Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Early replacement with coagulation factor XIII

Interventions/Control_2

Replacement with coagulation factor XIII over 2 weeks after recovery of inflammation and alimentation

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1) Patient with drain over 7 days for pancreatic fistula after pancreaticoduodenectomy or distal pancreatectomy
2) Coagulation factor XIII is 70% or less after postoperative day 7
3) CRP < 2mg/dl
4) Over 20 years old
5) Patients with written informed consent

Key exclusion criteria

1) Alb < 2.5g/dl
2) With other inflammation
3) Thrombotic disease
4) Hemolytic anemia or blood loss anemia
5) Compromised immune system or immunosuppressed
6) Patients who are judged inappropriate for the entry into the study by the investigator

Target sample size

50


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Akio Saiura

Organization

Cancer Institute Hospital

Division name

Department of Hepato-biliary-pancreatic surgery

Zip code


Address

3-8-31 Ariake, Koto-ku, Tokyo

TEL

03-3520-0111

Email

akio.saiura@jfcr.or.jp


Public contact

Name of contact person

1st name
Middle name
Last name Yoshinori Takeda

Organization

Cancer Institute Hospital

Division name

Department of Gastroenterological Surgery

Zip code


Address

3-8-31 Ariake, Koto-ku, Tokyo

TEL

03-3520-0111

Homepage URL


Email

yoshinori.takeda@jfcr.or.jp


Sponsor or person

Institute

Cancer Institute Hospital

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

がん研究会有明病院(東京都)


Other administrative information

Date of disclosure of the study information

2015 Year 10 Month 25 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications

https://link.springer.com/article/10.1007/s00423-018-1736-4

Number of participants that the trial has enrolled

50

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results

2018 Year 11 Month 30 Day

Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2015 Year 10 Month 10 Day

Date of IRB


Anticipated trial start date

2015 Year 10 Month 25 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2015 Year 10 Month 23 Day

Last modified on

2020 Year 02 Month 18 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000022425


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name